Form 4 for RCKT ROCKET PHARMACEUTICALS, INC.
Accepted 2025-11-20 00:00:00 ET · period of report 2025-11-18 · accession 0001140361-25-042856 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2025-11-20 | 2025-11-18 | RCKT | Schwartz Jonathan David | See Remarks | S - Sale | $2.98 | -2,545 | 299.1K | -0.8% | -$7,584 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2025-11-18 | S | D | 2,545 | $2.98 | 299,064 | D | — | — | (F1) Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. |